AJU Pharm 
Welcome,         Profile    Billing    Logout  
  Products    Diseases   Products    Trials    News 
5 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
recoflavone (DA-6034) / GL PharmTech, AJU Pharm
NCT06291194: Efficacy and Safety of AJU-S56 5% in Dry Eye Syndrome Patients

Recruiting
3
396
RoW
AJU-S56 5%, Test Group, Placebo Group(Vehicle), Control Group
AJU Pharm Co., Ltd., GL Pharm Tech Corporation
Dry Eye Syndromes
05/24
05/24
NCT06337981: Efficacy and Safety of AJU-S56 in Dry Eye Syndrome Patients

Completed
2
99
RoW
(AJU-S56 5% and placebo), Test 1 group(AJU-S56 5% and placebo, each 1 drop/1time, 3times in a day), AJU-S56 5%, Test 2 group(AJU-S56 5%, 1 drop/1time, 6times in a day), Placebo(Vehicle), Placebo group(Vehicle, 1 drop/1time, 6times in a day)
AJU Pharm Co., Ltd., GL Pharm Tech Corporation
Dry Eye Syndromes
06/22
11/22
GLH8NDE-201, NCT04679883: Phase 2 Clinical Trial to Evaluate the Efficacy and Safety of GLH8NDE in Patients With Dry Eye Disease

Not yet recruiting
2
99
RoW
5% GLH8NDE, Placebo
GL Pharm Tech Corporation
Dry Eye Syndromes
01/22
04/22
valsartan/amlodipine/chlorthalidone (AJU-C52L) / AJU Pharm
NCT06416865: Efficacy and Safety of AJU-C52 in Essential Hypertension Patients

Recruiting
3
190
RoW
AJU-C52L, AJU-C52, C52R1L, C52R1M
AJU Pharm Co., Ltd.
Essential Hypertension
12/22
08/24
NCT05077475: A Clinical Trial to Evaluate the Safety and Pharmacokinetics of AJU-C52L in Healthy Volunteers

Recruiting
1
60
RoW
C52R1H Tab. and C52R2 Tab., Reference Drug, AJU-C52L, Test Drug
AJU Pharm Co., Ltd.
Hypertension
04/22
04/22
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
recoflavone (DA-6034) / GL PharmTech, AJU Pharm
NCT06291194: Efficacy and Safety of AJU-S56 5% in Dry Eye Syndrome Patients

Recruiting
3
396
RoW
AJU-S56 5%, Test Group, Placebo Group(Vehicle), Control Group
AJU Pharm Co., Ltd., GL Pharm Tech Corporation
Dry Eye Syndromes
05/24
05/24
NCT06337981: Efficacy and Safety of AJU-S56 in Dry Eye Syndrome Patients

Completed
2
99
RoW
(AJU-S56 5% and placebo), Test 1 group(AJU-S56 5% and placebo, each 1 drop/1time, 3times in a day), AJU-S56 5%, Test 2 group(AJU-S56 5%, 1 drop/1time, 6times in a day), Placebo(Vehicle), Placebo group(Vehicle, 1 drop/1time, 6times in a day)
AJU Pharm Co., Ltd., GL Pharm Tech Corporation
Dry Eye Syndromes
06/22
11/22
GLH8NDE-201, NCT04679883: Phase 2 Clinical Trial to Evaluate the Efficacy and Safety of GLH8NDE in Patients With Dry Eye Disease

Not yet recruiting
2
99
RoW
5% GLH8NDE, Placebo
GL Pharm Tech Corporation
Dry Eye Syndromes
01/22
04/22
valsartan/amlodipine/chlorthalidone (AJU-C52L) / AJU Pharm
NCT06416865: Efficacy and Safety of AJU-C52 in Essential Hypertension Patients

Recruiting
3
190
RoW
AJU-C52L, AJU-C52, C52R1L, C52R1M
AJU Pharm Co., Ltd.
Essential Hypertension
12/22
08/24
NCT05077475: A Clinical Trial to Evaluate the Safety and Pharmacokinetics of AJU-C52L in Healthy Volunteers

Recruiting
1
60
RoW
C52R1H Tab. and C52R2 Tab., Reference Drug, AJU-C52L, Test Drug
AJU Pharm Co., Ltd.
Hypertension
04/22
04/22

Download Options